-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on Beam Therapeutics Inc (BEAM)
-
-
-
-
-
-
-
RBC on Beam Therapeutics Inc (BEAM): 'we view the data as incrementally positive'
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on Beam Therapeutics Inc (BEAM)
-
-
-
-
-
-
-
Beam, Inc. (BEAM) Misses Q3 EPS by 5c
-
-
-
-
-
-
-
Form SCHEDULE 13G/A Beam Therapeutics Inc. Filed by: ARK Investment Management LLC
-
-
-
-
-
-
-
Beam Therapeutics Inc. (BEAM) Granted FDA Orphan Drug Designation for BEAM-101
-
-
-
-
-
-
-
BofA Securities Upgrades Beam Therapeutics Inc (BEAM) to Buy
-
443,399 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

